Fatal Serotonin Syndrome Precipitated by Oxcarbazepine in a Patient Using an Selective Serotonin Reuptake Inhibitor

Abstract

Oxcarbazepine, a metabolite of carbamazepine, is used as an antiepileptic, analgesic for neuropathic pain and in the treatment of affective disorders. It has been approved by the Food and Drug Administration for partial seizures in adults as both adjunctive and monotherapy, and as adjunctive therapy in children aged from 2 to 16 years (http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4254b_07_05_KP%20OxcarbazepineFDAlabel102005.pdf). We present a case of serotonin syndrome, which was precipitated by this medicine in a patient who had been predisposed by long-term treatment with sertraline, a selective serotonin reuptake inhibitor. This is the first reported fatality due to this drug interaction and only the second case of serotonin syndrome reported with oxcarbazepine. Physicians should consider this risk when prescribing the above combination.

Management of severe arterial hypertension associated with serotonin syndrome: a case report analysis based on systematic review techniques

“…In addition, benzodiazepines can peripherally depress the baroreceptor reflex. [53][54][55][56] Cyproheptadine is an antihistamine with anticholinergic and antiserotonergic properties. It has antagonistic effects on several serotonin receptors including 5-HT1 A,D , 2 A,B,C , 3, 6 and 7.…”

Serotonergic and Adrenergic Drug Interactions Associated with Linezolid: A Critical Review and Practical Management Approach

“…[15][16][17] Three studies were excluded since they were published only as abstracts and 1 case report was excluded because serotonin syndrome was caused by a sertraline-oxcarbazepine interaction. 43 For serotonergic interactions, 6 retrospective studies were included. [13][14][15][16][17][18] The retrospective studies included 1 review of data from Phase 3 and 4 randomized controlled tri- Hunter Serotonin Toxicity Criteria Sternbach's Criteria Pt.…”